Patent ID: 11970482
Assignee: LIGAND PHARMACEUTICALS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 25:
26. The compound of claim 1, wherein R7is a 5-18 membered heteroaryl optionally substituted with one or more R29, wherein R29 is selected from the group consisting of C1-6alkyl, halo, cyano, hydroxy, C1-6alkoxy, haloC1-6alkyl, haloC1-6alkoxy, nitro, —C(═O)NR30R31, —(R32)C(═O)R33, —C(═O)OR34, —OC(═O)R35, and —C(═O)R36, and wherein each of R30, R31, R32, R33, R34, R35, and R36 is independently selected from the group consisting of hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, C3-7carbocyclyl, C6-10aryl, 5-10 membered heteroaryl, and 3-10 membered heterocyclyl.